REX加密股票溢价收益主动型ETF CEPI 深 沪
等待开盘 06-25 09:30:00 美东时间
33.60
-0.646
-1.89%
华盛通- 最 高34.29
- 今 开34.29
- 成交量 5.08万股
- 最 低 33.06
- 昨 收 34.246
- 总市值 1.11亿
- 52周最高 36.10
- 市盈率 静 --
- 换手率 1.53%
- 52周最低 24.4214
- 委 比 -99.50%
- 总股本 331.50万
- 历史最高 36.10
- 量 比 1.10
- 振 幅 3.59%
- 历史最低 13.2598
- 每 手 1
- 风险率 2.53%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Soligenix To Apply For Bundibugyo Ebola Vaccine Development Funding
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, noted
06-08 19:34
Soligenix seeks CEPI funding for Bundibugyo Ebola vaccine development
Soligenix seeks CEPI funding for Bundibugyo Ebola vaccine development Soligenix plans to apply to CEPI for funding to develop a Bundibugyo Ebola vaccine, following CEPI’s call for proposals due June 12, 2026. The bid is being prepared with University of Hawaiʻi at Mānoa researcher Axel Lehrer, aimin
06-08 19:31
OpenAI unveils Rosalind Biodefense program for biodefense, pandemic preparedness
OpenAI (OPENAI) said it is launching a program called Rosalind Biodefense to help trusted developers build new biodefense and pandemic preparedness capabilities. The AI start-up backed by Microsoft (M...
05-29 23:49
FACTBOX-What Bundibugyo Ebola vaccines and treatments are under development
FACTBOX-What Bundibugyo Ebola vaccines and treatments are under development Adds details on WHO recommendation throughout By Mariam Sunny and Jennifer Rigby May 29 (Reuters) - Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic Rep
05-29 19:00
Dyadic's Applied Biosolutions Unit Collaborates With Scripps Research To Evaluate Monoclonal Antibody And Vaccine Candidates Targeting Hantaviruses, Including Andes Virus
A series of recently reported hantavirus and Ebola cases worldwide have underscored the importance of pandemic preparedness and highlighted the need to improve the speed, scalability, flexibility, and cost-effectiveness
05-28 19:29
Transcript: Valneva Q1 2026 Earnings Conference Call
On Wednesday, Valneva (NASDAQ:VALN) discussed first-quarter financial results d...
05-13 23:51
中国电力建设企业协会：一季度中国清洁能源建设景气指数为106.77 同比下降6.66点 处于较景气区间
5月11日，中国电力建设企业协会发布2026年第一季度中国清洁能源建设景气指数(CEPI)和中国电力建设发展指数(PCDI)。
05-11 15:48
中国电力建设企业协会：一季度中国清洁能源建设景气指数为106.77 同比下降6.66点 处于较景气区间
5月11日，中国电力建设企业协会发布2026年第一季度中国清洁能源建设景气指数(CEPI)和中国电力建设发展指数(PCDI)。
05-11 15:48
Moderna's Legal Hit Steals Spotlight From Strong Sales
MRNA revenue hits $389M, beating Wall Street estimates. Despite a Q1 loss, Moderna eyes 10% growth and new flu vaccine approvals in 2026.
05-01 22:44
Moderna Reports Q1 2026 Results: Full Earnings Call Transcript
Moderna (NASDAQ:MRNA) reported first-quarter financial results on Friday. The t...
05-01 21:20
